Adrenomedullary Function in Cohort of Brazilian Pediatric Patients with Classic Congenital Adrenal Hyperplasia

Updata:01-01-1970

Source:
By:Talita Soriano Cruz Hovland, Izabel Calland Ricarte Beserra

DOI: https://doi.org/10.30564/jer.v2i1.2574

Abstract:

Congenital Adrenal Hyperplasia is a group of autosomal recessive disorders resulting from deficiency of enzymes essential for the synthesis of cortisol. Disease of the adrenal cortex, but there may be involvement adrenomedullary. Cortisol and epinephrine are directly related to the individual’s stress response. Lower values of epinephrine in children with congenital adrenal yperplasia could be related to increased clinical complications and hospitalizations rate. We evaluated the serum values of metanephrines and normetanephrines in children and adolescents with classic congenital adrenal hyperplasia and primary hypothyroidism and possible correlations with disease and hospitalizations. Cross-sectional study involved 29 patients (10 simple virilizing and 19 salt-wasting), and control group of 28 patients with primary hypothyroidism (10 overt and 18 subclinical). There were no differences in age (p = 0.24) and metanephrine (p = 0.34) or normetanephrine values (p = 0.85) between groups.Hospitalization rate was higher in the cases than in the controls (51 x 12).We conclude the serum values of metanephrine and normetanephrine in patients with congenital adrenal hyperplasia were within the normal values of reference, with no significant difference of group with primary hypothiroidism. The number of hospitalizations in the case was high in relation to the control, mainly in salt-wasting.

References:

[1] Merke D. P., Bornstein S. R. Congenital adrenal hyperplasia. The Lancet, 2005, 36: 2135-2136. [2] Ambroziak U., Bednarczuk T., Malinowska M. G.,Malunowicz E. M, Grzechocinska B., Kaminski P., Przedlacki J., Andziak E. B. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency -management in adults. Endokrynologia Polska/Polish Journal of Endocrinology, 2010, 61(1):142-155. . [3] Auchus R. J. Management of the adult with congenital adrenal hyperplasia. International Journal of Pediatric Endocrinology, 2010, 2010: 9. Article ID614107 [4] Pang S., Clark A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Molecular Genetics and Metabolism Reports. Screening, 1993, 2: 105-139. [5] Bradfort, L.T. Newborn screening for congenital adrenal hyperplasia. Endocrinology Metabolism Clinics North America, 2001, 30: 15-30. [6] Brasil. Ministério da Saúde. Portaria SAS/ MS no 16,Brasília, 15 Janeiro 2010. Protocolo Clínico e Diretrizes - Hiperplasia Adrenal Congênita. Disponível em: www.saude.gov.br. Access in: 20 mar 2018. [7] Kim M. S., Lienhard-Ryabets A., Bali R., Lane C.J., Park A. H., Hall S., Geffner M. E. Decreased drenomedullary Function in Infants With Classical Congenital Adrenal Hyperplasia. Journal of Clinical Endocrinology and Metabolism, 2014, 99(8): 1597-1601. [8] Merke D.P., Chrousos G P, Eisenhofer G., Weise M.,Keil M. F.; Rogol A. D.; Van WYK J. J., Bornstein S.R. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hidroxilase deficiency. New England Journal of Medicine, 2000, 343: 1362-1368. [9] Lisa, L., Bilelkl, R., Vrzalova, Z. Congenital adrenal hyperplasia and the function of adrenal medulla. Hormone Molecular Biology and Clinical Investigation,2010, 2(2): 245-248. [10] Bornstein, S.R., Tajima, T., Eisenhofer, G., Haindan A., Aguelera, G. Adrenomedullary function is severely impaired in 21/hydroxylase/deficient mice. The FASEB Journal, 1999, 13: 1185-1194. [11] Kronenberg, H. M., Melmed, S., Polonsky, Larsen, P.R. Williams Tratado de Endocrinologia. Tradução da 11a edição. Editora Elsevier, 2010. [12] Moreira, M. L., Novaes, H. M. D. Internações no Sistema de Serviços Hospitalares, SUS e não SUS:Brasil, 2006. Revista Brasileira de Epidemiologia,2011, 14(3): 411-422.

Tags: